Intention-to-treat: Methods for dealing with missing values in clinical trials of progressively deteriorating diseases

Statistics in Medicine

Volumn 20, Issue 24, 2001, Pages 3931-3946

  Tobi, Hilde ^a   Kuik, D Joop ^a   Bezemer, P Dick ^b   Ket, Paul ^a,b,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; ERROR; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; METHODOLOGY; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SIMULATION; SPINE FRACTURE; STATISTICAL ANALYSIS; TREATMENT FAILURE;

COMPUTER SIMULATION; DISEASE PROGRESSION; HUMANS; MODELS, STATISTICAL; OSTEOPOROSIS; PATIENT DROPOUTS; RANDOMIZED CONTROLLED TRIALS; SPINAL FRACTURES;

EID: 0035977410     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1149     Document Type: Article

References (24)

1. ICH E9 - Statistical Principles for Clinical Trials: Note for guidance on statistical principles for clinical trials
2. General design issues in efficacy, equivalency and superiority trials
3. A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis
4. Inference and missing data
5. Statistical Analysis with Missing Data
6. Missing data in longitudinal studies
7. Surrogate endpoints in clinical trials: Cardiovascular diseases
8. Response to reader reaction: Testing for random drop-outs in repeated measurement data
9. Comparing incomplete paired binomial data under non-random mechanism
10. Clinical Trials
11. Modeling the drop-out mechanism in repeated-measures studies
12. A new suggestion for the classification of missing values in the outcome of clinical trials
13. Designing clinical trials of treatment for osteoporosis: Recruitment and follow-up
14. A new approach to the analysis of clinical drug trials with withdrawals
15. Statistical Issues in Drug Development
16. Low molecular weight heparin compared with unfractioned heparin in prevention of postoperative thrombosis
17. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis
18. The randomized clinical trial: Bias in analysis
19. Sensitivity analysis by worst and best case assessment: Is it really sensitive?
20. Intention-to-treat in progressively deteriorating diseases: Should the last observation be carried forward?
21. Intention-to-treat: Umgang mit fehlenden Werten bei sich fortlaufend verschlechternden Zielgröβen in Therapiestudien
22. The application of the principle of intention-to-treat to the analysis of clinical trials